Cullgen Reports Positive Results from Phase 1 Study of its Novel Non-Opioid Product Candidate CG001419 for Pain

IND filing and initiation of Phase 2 clinical trials on track for 1H 2026SAN DIEGO, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Cullgen ...